Literature DB >> 28332880

PRECISION MEDICINE IN ADRENAL DISORDERS: THE NEXT GENERATION.

Hans K Ghayee, Aaron I Vinik, Karel Pacak.   

Abstract

OBJECTIVE: Discuss exciting new research in the area of adrenal disorders that has emerged in the last few years. Advances in genetics, biochemical diagnosis, and imaging modalities that have set new standards for diagnosis and treatment are described.
METHODS: A literature review was conducted on adrenal disorders using PubMed.
RESULTS: We highlight new developments in adrenal diseases from new genes discovered in aldosterone-producing adenomas, cortisol-producing tumors to pheochromocytomas/paragangliomas. In addition, we discuss new information regarding the question of whether nonfunctional adrenal adenomas are really functional or not. In congenital adrenal hyperplasia, emerging steroids that might be helpful in the near future for diagnostic purposes are discussed. New types of imaging are now available to identify endocrine neoplasms to help clinicians find lesions after biochemical confirmation.
CONCLUSION: The tremendous knowledge gained thus far in adrenal diseases sets the stage for not only new precision treatment modalities for individualized care but also for prevention. ABBREVIATIONS: ACC = adrenal cortical carcinoma; APA = aldosterone-producing adenoma; APCC = aldosterone-producing cell cluster; CAH = congenital adrenal hyperplasia; CT = computed tomography; DOTATATE = [68Ga]-DOTA(0)-Tyr(3)-octreotate; FDG = fluorodeoxyglucose; FH = fumarate hydratase; MR = miner-alocorticoid; MDH2 = malate dehydrogenase 2; PCC = pheochromocytoma; PET = positron emission tomography; PGL = paraganglioma; SCS = subclinical cortisol-secreting; SDHB = succinate dehydrogenase subunit B; TCGA = The Cancer Genome Atlas.

Entities:  

Mesh:

Year:  2017        PMID: 28332880      PMCID: PMC7454009          DOI: 10.4158/EP161716.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  52 in total

1.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

2.  Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Authors:  Iñaki Comino-Méndez; Francisco J Gracia-Aznárez; Francesca Schiavi; Iñigo Landa; Luis J Leandro-García; Rocío Letón; Emiliano Honrado; Rocío Ramos-Medina; Daniela Caronia; Guillermo Pita; Alvaro Gómez-Graña; Aguirre A de Cubas; Lucía Inglada-Pérez; Agnieszka Maliszewska; Elisa Taschin; Sara Bobisse; Giuseppe Pica; Paola Loli; Rafael Hernández-Lavado; José A Díaz; Mercedes Gómez-Morales; Anna González-Neira; Giovanna Roncador; Cristina Rodríguez-Antona; Javier Benítez; Massimo Mannelli; Giuseppe Opocher; Mercedes Robledo; Alberto Cascón
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

3.  A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.

Authors:  J B Maurice; R Troke; Z Win; R Ramachandran; A Al-Nahhas; M Naji; W Dhillo; K Meeran; A P Goldstone; N M Martin; J F Todd; F Palazzo; T Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-20       Impact factor: 9.236

4.  Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Graeme Eisenhofer; Kathryn S King; Jyotsna U Rao; Robert A Wesley; Karen T Adams; Karel Pacak
Journal:  J Natl Cancer Inst       Date:  2012-04-18       Impact factor: 13.506

5.  In Primary Aldosteronism, Mineralocorticoids Influence Exosomal Sodium-Chloride Cotransporter Abundance.

Authors:  Martin J Wolley; Aihua Wu; Shengxin Xu; Richard D Gordon; Robert A Fenton; Michael Stowasser
Journal:  J Am Soc Nephrol       Date:  2016-07-05       Impact factor: 10.121

6.  Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.

Authors:  Alberto Cascón; Iñaki Comino-Méndez; María Currás-Freixes; Aguirre A de Cubas; Laura Contreras; Susan Richter; Mirko Peitzsch; Veronika Mancikova; Lucía Inglada-Pérez; Andrés Pérez-Barrios; María Calatayud; Sharona Azriel; Rosa Villar-Vicente; Javier Aller; Fernando Setién; Sebastian Moran; Juan F Garcia; Ana Río-Machín; Rocío Letón; Álvaro Gómez-Graña; María Apellániz-Ruiz; Giovanna Roncador; Manel Esteller; Cristina Rodríguez-Antona; Jorgina Satrústegui; Graeme Eisenhofer; Miguel Urioste; Mercedes Robledo
Journal:  J Natl Cancer Inst       Date:  2015-03-11       Impact factor: 13.506

7.  Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.

Authors:  Susan Richter; Mirko Peitzsch; Elena Rapizzi; Jacques W Lenders; Nan Qin; Aguirre A de Cubas; Francesca Schiavi; Jyotsna U Rao; Felix Beuschlein; Marcus Quinkler; Henri J Timmers; Giuseppe Opocher; Massimo Mannelli; Karel Pacak; Mercedes Robledo; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

8.  Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.

Authors:  Koshiro Nishimoto; Scott A Tomlins; Rork Kuick; Andi K Cani; Thomas J Giordano; Daniel H Hovelson; Chia-Jen Liu; Aalok R Sanjanwala; Michael A Edwards; Celso E Gomez-Sanchez; Kazutaka Nanba; William E Rainey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

9.  [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.

Authors:  Stefanie Hahner; Andrea Stuermer; Michael Kreissl; Christoph Reiners; Martin Fassnacht; Heribert Haenscheid; Felix Beuschlein; Martina Zink; Katharina Lang; Bruno Allolio; Andreas Schirbel
Journal:  J Clin Endocrinol Metab       Date:  2008-04-08       Impact factor: 5.958

10.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Authors:  Ute I Scholl; Gerald Goh; Gabriel Stölting; Regina Campos de Oliveira; Murim Choi; John D Overton; Annabelle L Fonseca; Reju Korah; Lee F Starker; John W Kunstman; Manju L Prasad; Erum A Hartung; Nelly Mauras; Matthew R Benson; Tammy Brady; Jay R Shapiro; Erin Loring; Carol Nelson-Williams; Steven K Libutti; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Peyman Björklund; Tobias Carling; Christoph Fahlke; Patricia Hidalgo; Richard P Lifton
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

View more
  1 in total

1.  Grand Challenge in Adrenal Endocrinology: Is the Legacy of the Past a Challenge for the Future of Precision Medicine?

Authors:  Iacopo Chiodini; Luigi Gennari
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-03       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.